UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective

Current oncology (Toronto), 2023-12, Vol.30 (12), p.10477-10487

2023

Volltextzugriff (PDF)

Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status

Current oncology (Toronto), 2022-01, Vol.29 (1), p.383-391

2022

Volltextzugriff (PDF)

Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group

The oncologist (Dayton, Ohio), 2020-05, Vol.25 (5), p.422-430

2020

Volltextzugriff (PDF)

Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials

Breast cancer (Tokyo, Japan), 2018-07, Vol.25 (4), p.479-488

2018

Volltextzugriff (PDF)

Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape

Current oncology (Toronto), 2023-12, Vol.31 (1), p.145-167

2023

Volltextzugriff (PDF)

The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1376-1388

2024

Volltextzugriff (PDF)

Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey

Current oncology (Toronto), 2021-12, Vol.28 (6), p.5215-5226

2021

Volltextzugriff (PDF)

Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey

Current oncology (Toronto), 2021-12, Vol.29 (1), p.1-13

2021

Volltextzugriff (PDF)

Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?

Current oncology (Toronto), 2021-07, Vol.28 (4), p.2523-2528

2021

Volltextzugriff (PDF)

De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis

Cancer treatment reviews, 2021-09, Vol.99, p.102254-102254, Article 102254

2021

Volltextzugriff (PDF)

Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective

Current oncology (Toronto), 2022-06, Vol.29 (6), p.4125-4137

2022

Volltextzugriff (PDF)

An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma

European urology focus, 2020-01, Vol.6 (1), p.34-36

2020

Volltextzugriff (PDF)

Evaluation of Unsolicited Feedback from Patients with Cancer and Their Families as a Strategy to Improve Cancer Care Delivery

Current oncology (Toronto), 2024-05, Vol.31 (5), p.2488-2496

2024

Volltextzugriff (PDF)

phosphatidylinositol 4-kinase PI4KIIIα is required for the recruitment of GBF1 to Golgi membranes

Journal of cell science, 2010-07, Vol.123 (13), p.2273-2280

2010

Volltextzugriff (PDF)

Improving Care for Older Adults with Cancer in Canada: A Call to Action

Current oncology (Toronto), 2024-07, Vol.31 (7), p.3783-3797

2024

Volltextzugriff (PDF)

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Current oncology (Toronto), 2024-08, Vol.31 (8), p.4531-4545

2024

Volltextzugriff (PDF)

Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets

JCO clinical cancer informatics, 2023-09, Vol.7 (7), p.e2300116

2023

Volltextzugriff (PDF)

Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer

American Society of Clinical Oncology educational book, 2019-05, Vol.39 (39), p.e8-e21

2019

Volltextzugriff (PDF)

Risks and Benefits of Rituximab Maintenance in Elderly Patients with Advanced Follicular Lymphoma

Blood, 2016-12, Vol.128 (22), p.5329-5329

2016

Volltextzugriff (PDF)

Abstract OT1-11-02: A pragmatic, randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy and its effects on tolerability and compliance (REaCT-CHRONO Study)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-11-02-OT1-11-02

2022

Volltextzugriff (PDF)

A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer

Breast cancer research and treatment, 2024-07

2024

Volltextzugriff (PDF)

Abstract OT2-21-01: A randomized, multicenter pragmatic trial comparing bone pain from a single dose of pegfilgrastim to 5 doses of daily filgrastim in breast cancer patients receiving neoadjuvant/adjuvant chemotherapy (REaCT-5G)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT2-21-01-OT2-21-01

2022

Volltextzugriff (PDF)

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT1-01-01-OT1-01-01

2022

Volltextzugriff (PDF)

Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey

Supportive care in cancer, 2021-11, Vol.29 (11), p.6903-6912

2021

Volltextzugriff (PDF)

Abstract PO3-11-12: A Pragmatic Randomized Trial Comparing Morning versus Evening Dosing of Endocrine Therapy for Early Breast Cancer: Final Results (REaCT-CHRONO Study)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO3-11-12-PO3-11-12

2024

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(51)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective

Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status

Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group

Cyclin-dependent kinase 4/6 inhibitors as first-line treatment for post-menopausal metastatic hormone receptor-positive breast cancer patients: a systematic review and meta-analysis of phase III randomized clinical trials

Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape

The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care

Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey

Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey

Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?

De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis

Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective

An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma

Evaluation of Unsolicited Feedback from Patients with Cancer and Their Families as a Strategy to Improve Cancer Care Delivery

phosphatidylinositol 4-kinase PI4KIIIα is required for the recruitment of GBF1 to Golgi membranes

Improving Care for Older Adults with Cancer in Canada: A Call to Action

A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer

Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Data Sets

Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer

Risks and Benefits of Rituximab Maintenance in Elderly Patients with Advanced Follicular Lymphoma

Abstract OT1-11-02: A pragmatic, randomised, multicentre trial evaluating the dose timing (morning vs evening) of endocrine therapy and its effects on tolerability and compliance (REaCT-CHRONO Study)

A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer

Abstract OT2-21-01: A randomized, multicenter pragmatic trial comparing bone pain from a single dose of pegfilgrastim to 5 doses of daily filgrastim in breast cancer patients receiving neoadjuvant/adjuvant chemotherapy (REaCT-5G)

Abstract OT1-01-01: A randomized, pragmatic trial investigating the timing of radiotherapy and endocrine in patients with early stage breast cancer (REaCT-RETT trial)

Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey

Abstract PO3-11-12: A Pragmatic Randomized Trial Comparing Morning versus Evening Dosing of Endocrine Therapy for Early Breast Cancer: Final Results (REaCT-CHRONO Study)

Suchergebnisse filtern